rdf:type |
|
lifeskim:mentions |
umls-concept:C0004048,
umls-concept:C0030705,
umls-concept:C0032952,
umls-concept:C0034380,
umls-concept:C0035203,
umls-concept:C0066700,
umls-concept:C0392756,
umls-concept:C0442027,
umls-concept:C1272745,
umls-concept:C1514873,
umls-concept:C1960048
|
pubmed:issue |
5
|
pubmed:dateCreated |
2000-12-4
|
pubmed:abstractText |
Inhaled corticosteroid therapy in severe persistent asthma has been shown to reduce or eliminate oral corticosteroid (OCS) use while retaining effective asthma control.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0091-6749
|
pubmed:author |
pubmed-author:BenschG WGW,
pubmed-author:BergerWW,
pubmed-author:BernsteinD IDI,
pubmed-author:BronskyE AEA,
pubmed-author:CraigT JTJ,
pubmed-author:DegraffA CAC,
pubmed-author:FiskJ BJB,
pubmed-author:FrigasEE,
pubmed-author:GarayS MSM,
pubmed-author:GowerR GRG,
pubmed-author:GraftD FDF,
pubmed-author:GrossmanJJ,
pubmed-author:HarrisonJ EJE,
pubmed-author:KarpelJ PJP,
pubmed-author:LefleinJ GJG,
pubmed-author:NathanRR,
pubmed-author:NolopK BKB,
pubmed-author:NoonanMM,
pubmed-author:RamsdellJ WJW,
pubmed-author:RooklinA RAR,
pubmed-author:SchenkelE JEJ,
pubmed-author:ShneyerLL,
pubmed-author:SilvermanBB,
pubmed-author:WebbD RDR
|
pubmed:issnType |
Print
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
852-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11080706-Administration, Inhalation,
pubmed-meshheading:11080706-Administration, Oral,
pubmed-meshheading:11080706-Adolescent,
pubmed-meshheading:11080706-Adult,
pubmed-meshheading:11080706-Aged,
pubmed-meshheading:11080706-Anti-Asthmatic Agents,
pubmed-meshheading:11080706-Anti-Inflammatory Agents,
pubmed-meshheading:11080706-Asthma,
pubmed-meshheading:11080706-Consumer Product Safety,
pubmed-meshheading:11080706-Double-Blind Method,
pubmed-meshheading:11080706-Female,
pubmed-meshheading:11080706-Glucocorticoids,
pubmed-meshheading:11080706-Health Status,
pubmed-meshheading:11080706-Humans,
pubmed-meshheading:11080706-Male,
pubmed-meshheading:11080706-Middle Aged,
pubmed-meshheading:11080706-Prednisone,
pubmed-meshheading:11080706-Pregnadienediols,
pubmed-meshheading:11080706-Quality of Life,
pubmed-meshheading:11080706-Respiratory Function Tests
|
pubmed:year |
2000
|
pubmed:articleTitle |
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
|
pubmed:affiliation |
Department of Pulmonary Medicine, Thomas Jefferson Hospital, Philadelphia, PA, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|